Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAS2R41 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | CD160 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | ZNF567 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | HMGXB4 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | VASH1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | PNO1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | AC073610.5 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | TMEM154 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | RNF207 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | ACTL10 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |